comparemela.com

Latest Breaking News On - Eris lifesciences - Page 15 : comparemela.com

Biocon gains on UK health agency s marketing nod to subsidiary for ophthalmic biosimilar

Earlier in this month, Eris Lifesciences has signed a definitive agreement with Biocon Biologics to acquire its Branded Formulations’ India (BFI) business units of nephrology and dermatology.

United kingdomBiocon biologicsEuropean unionRegulatory agencyEuropean commissionEris lifesciencesBranded formulation indiaBiocon share price today

NPPA makes 33 fixed-dose combination drugs cheaper, brings them under regulation

The 33 drugs includes two each from JB Chemicals and Pharmaceuticals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharmaceutical, and Sanofi India and one from Torrent Pharma.

Delhi high courtServices taxNational pharmaceutical pricing authorityEris lifesciencesZydus healthcareSun pharmaceuticalSanofi indiaMaximum retail priceJb chemicals and pharmaceuticalsEris lifesciencesZydus healthcareSun pharmaceuticalNational pharmaceutical pricing authority nppa

Biocon Biologics announces divestment

Biocon Biologics Limited , a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON), today announced that it has entered into a definitive agreement with Eris Lifesciences (Eris) for the divesture of its Dermatology and Nephrology branded formulations business units in India that mostly comprised of its legacy small molecules’ brands. The transaction is a

Shreehas tambeBiocon biologicsAmit bakshiEris lifesciences ltdBiocon limitedBiocon biologics limitedEris lifesciencesSlump saleBranded formulationsManaging directorBiocon biologic nephrologyDermatology branded formulations

Biocon Q2 results: Net profit more than doubles to Rs 172 7 crore

Biocon Q2 earnings: The company reported a profit of Rs 414.5crore in the same period of the previous year

Drug administrationEris lifesciencesOfficial action indicatedBiocon q2 earningsBiocon q2 resultsIocon q2 earnings updatesIocon q2 results updatesIocon quarterly resultsBiocon q2 profitBiocon share priceIocon stocks priceIocon share price updatesIocon stock price updates

Biocon reports net profit of ₹172 7 crore in Q2 - The Hindu BusinessLine

Biocon reports net profit of ₹172 7 crore in Q2 - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Biocon biologicsEris lifesciences

vimarsana © 2020. All Rights Reserved.